Thermo Fisher Scientific ASAH2 Polyclonal Antibody

Applications and Tested Dilution

Product Specifications

Product Specific Information

Immunogen sequence:
TATQTSPVPL TPESPLFQNF SGYHIGVGRA DCTGQVADIN LMGYGKSGQN AQGILTRLYS RAFIMAEPDG SNRTVFVSID IGMVSQRLRL EVLNRLQSKY GSLYRRDNVI LSGTHTHSGP AGYFQYTVFV IASEGFSNQT FQHMVTGILK SIDIAHTNMK PGKIFINKGN VDGVQINRSP YSYLQNPQSE RARYSSNTDK EMIVLKMVDL NGDDLGLISW FAIHPVSMNN SNHLVNSDNV GYASYLLEQE KNKGYLPGQG P

Positive Samples: 22Rv1, Mouse kidney, Rat kidney
Cellular Location: Cell membrane, Single-pass type II membrane protein

Target Information

Sphingolipids are hydrolyzed by ceramidases to yield sphingosine and fatty acids. These ceramidases are classified according to the pH range that supports their optimal activity.
ASAH2 is a neutral ceramidase and a key regulator of sphingolipid signaling metabolites at the cell surface, catalyzing the hydrolysis of the N-acyl linkage of ceramide at an optimal pH of 6.5–8.5.
It is a type II integral membrane protein that can be cleaved to yield a soluble secreted form and acts as a repressor of apoptosis by reducing C16-ceramide and generating sphingosine.
Sphingosine has both mitogenic and apoptosis-inducing activities, and its phosphorylated form functions as an intra- and intercellular second messenger.
ASAH2 is ubiquitously expressed, with higher levels in the intestine, kidney, skeletal muscle, and heart. It plays a key role in the catabolism of dietary sphingolipids and regulation of bioactive sphingolipid metabolites in the intestinal tract.

For Research Use Only.
Not for use in diagnostic procedures. Not for resale without express authorization.